Interpace Biosciences IncのROIC
Interpace Biosciences IncのROICは何ですか。
Interpace Biosciences IncのROICは108.21%です。
ROICの定義は何ですか。
Return on invested capital (ROIC) is a financial ratio that measures how efficient a company is at allocating the capital under its control to profitable investments.
= NOPAT / Invested capital = EBIT * (1 - tax rate) / (2-year average liabilities + 2-year average shareholder equity)
Return on invested capital (ROIC) ratio gives investors a sense of how well a company is using money under its control to generate profitable returns.
ROIC can be used as a benchmark to calculate the valuation of companies across industries. A higher ROIC means the company is doing a better job of investing the money from shareholders and bondholders to run the business. A company is creating value if its ROIC exceeds 2%. If its ROIC is under 2%, the company is likely destroying value and has no excess capital to invest in future growth.
You can calculate ROIC with the following formula:
NOPAT = Net operating profit after tax
Invested Capital = Average total liabilities + Average shareholders' equity
The averages of liabilities and shareholders' equity are calculated as geometrical averages of the last two annual values from the company's balance sheet.
NASDAQのセクタHealth CareにおけるROICの企業と比べるInterpace Biosciences Inc
Interpace Biosciences Incは何をしますか。
advancing patient care through molecular diagnostic testing. interpace diagnostics develops molecular diagnostic tests. our molecular diagnostic tests provide unparalleled accuracy and clarity to improve outcomes in patients facing a cancer diagnosis. you can be assured that all of the molecular tests we offer are driven by rigorous, validated science. we power the future of molecular diagnostics, delivering cutting-edge and much-needed mutational analysis that helps risk-stratify for thyroid, pancreatic, and other cancers to better inform treatment decisions. the unique molecular diagnostic tests we offer enable healthcare providers to avoid unnecessary surgeries and better assess the risk of cancer progression in their patients.
Interpace Biosciences Incと類似のroic
- ESG Global Impact CapitalのROICは96.25%です。
- Davidstea IncのROICは96.69%です。
- Onoff AGのROICは97.15%です。
- ThreeD CapitalのROICは97.77%です。
- Golden MatrixのROICは99.52%です。
- BoomerのROICは108.06%です。
- Interpace Biosciences IncのROICは108.21%です。
- Hawks Acquisition CorpのROICは108.59%です。
- Goldflare Exploration IncのROICは110.33%です。
- BioNTech SEのROICは110.80%です。
- National Cinemedia IncのROICは112.03%です。
- 48475のROICは113.60%です。
- Athena Technology Acquisition IIのROICは113.88%です。